Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
36,72 € ↓ -1,56 (-4,08%)
2026-06-02
PREZZO DELLE AZIONI
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionSofos Investments, Inc.
Latest Disclosed Ownership51,858 shares
Latest Disclosed Value $ 1,905,782
Sofos Investments, Inc. reports 12.69% increase in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 8, 2026 - Sofos Investments, Inc. filed a 13F-HR form disclosing ownership of 51,858 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $1,636,120 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 46,020 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 12.69% during the quarter. The current value of the position is $1,904,226 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F NOVO-NORDISK A S FSPONSORED ADR 1 ADR REPS 1 ORD SHS AMERICAN DEPOSITORY 670100205 51,858 5,838 12.69 1,906 -18.62 0.3391
2026-02-13 2025-12-31 13F NOVO-NORDISK A S FSPONSORED ADR 1 ADR REPS 1 ORD SHS AMERICAN DEPOSITORY 670100205 46,020 7,132 18.34 2,341 8.53 0.4507
2025-11-14 2025-09-30 13F NOVO-NORDISK A S AMERICAN DEPOSITORY 670100205 38,888 13,158 51.14 2,158 20.77 0.4265
2025-04-30 2025-03-31 13F NOVO-NORDISK A S FSPONSORED ADR 1 ADR REPS 1 ORD SHS AMERICAN DEPOSITORY 670100205 25,730 2,348 10.04 1,787 -46.48 0.3896
2024-08-06 2024-06-30 13F NOVO-NORDISK A S AMERICAN DEPOSITORY 670100205 23,382 -127 -0.54 3,338 37.16 0.8335
2024-06-26 2024-03-31 13F/A-1 NOVO-NORDISK A S AMERICAN DEPOSITORY 670100205 23,509 -2 -0.01 2,434 0.04 0.6846
2024-05-13 2024-03-31 13F Novo Nordisk ADR 670100205 23,177 -334 2,976 0.7627
2024-06-26 2023-12-31 13F/A-1 NOVO-NORDISK AS VORMAL F AMERICAN DEPOSITORY 670100205 23,511 -231,485 -90.78 2,432 -98.33 0.6833
2024-02-15 2023-12-31 13F NOVO-NORDISK A S AMERICAN DEPOSITORY 670100205 254,996 0 145,765 1.6062
2023-11-16 2023-09-30 13F NOVO-NORDISK A S AMERICAN DEPOSITORY 670100205 254,996 246,334 2,843.85 145,765 7,288,150.00 1.6062
2023-08-09 2023-06-30 13F NOVO-NORDISK A S ADR SPONSORED 670100205 8,662 -261 -2.93 2 -60.00 0.0060
2023-05-12 2023-03-31 13F NOVO-NORDISK A S ADR SPONSORED 670100205 8,923 6,003 205.58 6 400.00 0.1771
2023-02-15 2022-12-31 13F NOVO-NORDISK A S International Equities 670100205 2,920 -384 -11.62 1 0.0069
2022-11-03 2022-09-30 13F NOVO-NORDISK A S ADR SPONSORED 670100205 3,304 -5,775 -63.61 0 0.0096
2022-08-05 2022-06-30 13F NOVO-NORDISK A S ADR 670100205 9,079 5,427 148.60 1 0.0291
2022-05-13 2022-03-31 13F NOVO-NORDISK A S ADR SPONSORED 670100205 3,652 -4,104 -52.91 0 0.0095
2022-02-11 2021-12-31 13F NOVO-NORDISK A S ADR 670100205 7,756 1,070 16.00 1 0.0154
2021-11-12 2021-09-30 13F NOVO-NORDISK A S ADR 670100205 6,686 -8,376 -55.61 1 -100.00 0.3441
2021-08-11 2021-06-30 13F NOVO-NORDISK A S ADR 670100205 15,062 1,417 10.38 1 0.4822
2021-05-17 2021-03-31 13F NOVO-NORDISK A S ADR 670100205 13,645 6,013 78.79 1 -100.00 0.0191
2021-02-16 2020-12-31 13F NOVO-NORDISK A S ADR 670100205 7,632 7,632 532 0.4871
2020-08-13 2020-06-30 13F NOVO-NORDISK A S ADR 670100205 0 -1,986 -100.00 0 -100.00
2020-05-12 2020-03-31 13F NOVO-NORDISK A S ADR 670100205 1,986 1,882 1,809.62 9 -86.21 0.0276
2020-02-28 2019-12-31 13F NOVO-NORDISK A S ADR 670100205 104 16 18.18 58 1,060.00 0.0400
2019-10-15 2019-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 88 -24 -21.43 5 -16.67 0.0043
2019-07-26 2019-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 112 -85 -43.15 6 -40.00 0.0049
2019-04-19 2019-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 197 93 89.42 10 150.00 0.0081
2018-10-31 2018-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 104 -7 -6.31 4 -20.00 0.0042
2018-08-14 2018-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 111 -8 -6.72 5 -16.67 0.0047
2018-05-23 2018-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 119 119 6 0.0061
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.